삼성서울병원

Ko En

Radiation Oncology Park, Hee Chul M.D

Expertise
Liver cancer, biliary and pancreatic cancer, rectal cancer, radiation therapy, proton therapy
Treament Schedule 11 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
AM
PM
Treament Schedule 12 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
TUE
31
AM
PM

Medical Education

2002~2004 Ph.D. in Medicine Yonsei University, Korea
1999~2001 Master of Science Yonsei University, Korea
1986~1992 Medical Doctor College of Medicine, Yonsei University, Korea

Post-Graduate Training

Fellowship   2001~2001 Department of Radiation Oncology, Yonsei University College of Medicine, Korea
Residency   1996~2000 Department of Radiation Oncology, Severance Hospital, Korea
Internship   1992~1993 Severance Hospital, Korea

Professional Appointments

2021~Present Chair Department of Radiation Oncology, Samsung Medical Center
2016~Present Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2010~2015 Associate Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2006~2007 Visiting Scientist Department of Radiation Oncology, MD Anderson Cancer Center, USA
2006~2006 Honorable Visiting Instructor Department of Radiology, Hokkaido University Hospital, Japan
2001~2005 Assistant Professor Department of Radiation Oncology, Hallym University College of Medicine

Professional Memberships

1996~Present Member The Korean Society for Radiation Oncology
2009~Present Member The Korean Liver Cancer Association
2008~Present Member Korean Society of Medical Oncology

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-90065-1 Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma Lee1, JH; Yoo, GS; Yoon, YC; Park, HC; Kim, HS
    View PubMed
  • INT J MOL SCI 2021 10.3390/ijms22052637 Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments Shin1, SW; Yang, K; Lee, M; Moon, J; Son, A; Kim, Y; Choi, S; Kim, D; Choi, C; Lee, N; Park, HC
    View PubMed
  • CELLS 2021 10.3390/cells10030554 Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells Choi1, C; Lee, GH; Son, A; Yoo, GS; Yu, JI; Park, HC
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-82177-5 Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma Yu1, JI; Park, HC; Yoo, GS; Choi, C; Choi, MS; Nam, H; Baek, SY; Park, M
    View PubMed